Nevada
AMPLIFIED: New autism treatment offers hope to Nevada families
LAS VEGAS (FOX5) — A medication traditionally used in cancer treatment has received FDA fast-track approval as a new therapy for children with autism, offering hope to Nevada families seeking treatment options.
Leucovorin, a generic drug typically used with cancer patients undergoing chemotherapy, was fast-tracked for FDA approval in September 2025 for autism treatment. The medication works as a folic acid supplement for children who have a folic acid deficit.
“It’s a new medication in the sense of treating children with autism. It’s not a new drug, though. It’s been around. It’s typically been used with cancer patients undergoing chemo,” said FOX5 reporter Talia Kirkland. “So new, but not so new, if that makes sense.”
Las Vegas family tries new treatment
Seven-year-old Christopher Wilson, who has autism and is nonverbal, is among the first Nevada children to try the new treatment. His father, Sean Wilson, said the family was desperate for answers after Christopher was diagnosed as an infant.
“Even getting a diagnosis can be difficult,” Kirkland said, describing the Wilson family’s experience. “So there’s already some type of hardship that these families go through from the beginning.”
Christopher experienced what doctors initially thought was blindness at birth before receiving his autism diagnosis. The family has been using leucovorin for about 30 days under the care of a local pediatric neurologist.
“Little bottle of hope”
The autism community has embraced leucovorin with cautious optimism, with some calling it “the little bottle of hope.”
Shawn Wilson, Christopher’s father, told FOX5 he had read stories online about dramatic improvements.
“I’ve read stories where sometimes when they begin using leucovorin, he’s seen that one, two, three day and then the child is talking,” Kirkland said, describing Wilson’s research.
However, the Wilson family has not yet seen major improvements after 30 days of treatment.
Doctor emphasizes realistic expectations
Dr. Devraj Chavda, one of the few pediatric neurologists in Las Vegas, is prescribing the medication but emphasizes realistic expectations for families.
“We shouldn’t look at autism as something that is curable. He kept saying that, you know, it’s treatable,” Kirkland said, describing the doctor’s approach. “And even he told Shawn with trying this medication with Christopher, that this is a treatment [not a cure].”
The doctor explained that even if the medication helps children begin speaking, medical professionals still need to determine the root cause of speech delays.
“Even if we get those amazing results where he does begin to speak, we still have to figure out what was the root cause, what was blocking that speech,” Kirkland said.
Limited specialists create challenges
Finding medical experts for the story proved challenging due to Nevada’s shortage of pediatric specialists. The reporting process, which began in November 2025, took months to complete because of the limited number of pediatric neurologists in the Las Vegas area.
“That even just from a journalistic point of view, to find experts is difficult,” Kirkland said. “There are so few pediatric neurologists in this area.”
Federal study planned for 2026
While Christopher Wilson is not part of an official study, the federal government plans to conduct a major trial of leucovorin for autism treatment in 2026. Currently, children like Christopher are receiving the medication anecdotally through their doctors.
“His doctor, I’m sure, is with every patient that he’s prescribing this. I’m sure he’s watching and keeping very detailed notes just to see how this works,” Kirkland said.
Concerns about generic medication quality
Because leucovorin is a generic drug, doctors have concerns about quality.
“One of the big concerns is that because it’s a generic, generics can vary a little,” Kirkland said. “So doctors do have that concern that if we’re using this medication in this capacity, that the quality is all going to be standard across the board.”
Parent’s perspective
Despite not seeing immediate results, Shawn Wilson remains committed to trying the treatment for his son.
“You just want to do the best thing you can do for your kid. You want to help them out, and you want them to have as normal of a life as you would expect,” Shawn said.
Copyright 2026 KVVU. All rights reserved.
Nevada
Fatal crash on US-95 in Nye County
LAS VEGAS (FOX5) — One woman is dead following a head-on collision on US-95 Sunday afternoon.
Nevada Highway Patrol responded to a report of a crash at 4:41 p.m. at mile marker 105, approximately 45 miles north of Beatty. The crash involved two sport utility vehicles.
One adult female driver was confirmed dead at the scene. The other driver was transported to a local area hospital with injuries.
MORE ON FOX5: Report: Nevada traffic deaths down 33% for April
No road closures are in effect. Investigations are being conducted on the southbound shoulder area.
Nevada Highway Patrol, a division of the Nevada State Police, is asking motorists to slow down and use caution in the area as troopers and investigators work at the scene.
Further information will be provided following the preliminary investigation.
Copyright 2026 KVVU. All rights reserved.
Nevada
Northern Nevada gardens and backyards: Controlling insects with systemic insecticides – Carson Now
Last week I wrote about soft versus armored scale insects. Soft scales exude honeydew, are protected by ants and can be controlled by systemic insecticides, some of which have the active ingredient imidacloprid. Armored scales do not emit honeydew and are not managed by an imidacloprid insecticide.
Imidacloprid is a systemic neonicotinoid insecticide that is designed to kill piercing/sucking insects via damage to their nervous system. Systemic means it is applied on the leaves, stems or as a soil drench and spreads internally throughout the plant. When an insect feeds on any part of the plant such as the pollen, nectar, flowers, fruit, leaves, or other plant tissues, it ingests the toxic chemical and dies.
Systemic insecticides can kill not only pests such as soft scales, but also their natural enemies and non-target/beneficial insects such as bees and other pollinators, including butterflies, moths and their larvae. They also can “adversely affect reproduction, growth, insect immune systems, learning, flying, or other attributes even at concentrations too low to cause death outright.” Native bees, who often nest in the ground, can be more susceptible than honeybees, particularly to soil drench applications.
Systemic insecticides kill over time at a steady concentration, which can cause a longer toxic exposure. Although it is often suggested to apply in the evening when insects aren’t out, or after flowering season, harmful exposures can still occur. These chemicals can last for months or years in soil. They sometimes leach into groundwater but fortunately are usually only slightly toxic to fish. One application may provide season long control.
Chemical insecticides are always a last resort. The risks versus benefits must be carefully evaluated. A healthy thriving plant is one of the best defenses against scale or other insect damage. Good watering, the appropriate amount of fertilizer and maintenance keep a plant resistant to attacks. Predators, including lady beetles, bugs and lacewings, play an important part in pest management.
Plant a diversity of flowering plants to attract and feed natural enemies. Sometimes when you see scales on a plant, they may have already been parasitized by parasitic wasps. If a large number are parasitized, there are eggs in or on each scale eating away at them. Sometimes scales are no longer alive and do not require a pesticide treatment. Check before applying insecticides. Using tape traps to monitor crawlers will help you accurately time the use of horticulture oils, Neem oil or insecticidal soap. Dormant oil treatment on deciduous woody plants will help kill overwintering scale pests and reduce future populations.
JoAnne Skelly is an Associate Professor and Extension Educator, Emerita, University of Nevada Cooperative Extension. She can be reached at skellyj@unr.edu.
Related
Nevada
Communities In Schools of Nevada hires new CEO, state director
Communities In Schools of Nevada,
among the largest affiliates of a leading evidence-based dropout prevention nonprofit organization, announced a planned leadership transition effective July 13.
Tami Hance-Lehr, chief executive office and state director, plans to retire. Succeeding her, Alex Bybee has been named the next CEO and state director.
“Tami’s leadership, not only across Nevada, but throughout the Communities In Schools national network is marked with incredible success,” said Raymond Specht, board chair of CIS of Nevada. “What she has demonstrated when student supports are prioritized, along with her vision to strengthen partnerships, advance policy and expand access to wraparound evidence-based support is leaving a legacy for the over two-decade strong organization.”
Bybee returns to CIS of Nevada after founding and leading Bybee Co., a consulting practice focused on cross-sector strategies for social impact.
-
North Dakota5 minutes agoTravis Bell sentenced to 6 years in crash that killed Grand Forks girl
-
Ohio11 minutes agoWoman dies after Monday morning crash in Columbiana County
-
Oklahoma17 minutes agoScotfest Oklahoma returns in 2026, will be final event for historic festival
-
Oregon23 minutes agoMarion County sheriff releases sex offender information under Oregon public safety law
-
Rhode Island35 minutes ago
Rhode Island Philharmonic Orchestra announces 2026 Summer Pops schedule
-
South-Carolina41 minutes agoCommentary: Echoes of yesterday in today’s SC redistricting debate
-
South Dakota47 minutes agoEastern South Dakota farmer finishes planting ahead of schedule – Brownfield Ag News
-
Tennessee53 minutes ago
18 officer-involved shooting cases statewide so far in 2026, per TBI